Home
Home
  • Home
  • About Us About Us
    • Overview
    • Who we are
    • Why we provide advice
    • What are health technologies
    • Meetings
    • News
    • Who we work with
    • Contact Us
  • What We Do What We Do
    • Overview
    • Our Strategy
    • Work programme
    • Range of advice products
    • Quarterly Bulletin of advice
    • Early HTA Advice Service
  • Our Advice
  • Request Advice Request Advice
    • Overview
    • Form for requesting advice
  • Get Involved Get Involved
    • Overview
    • Contribute to advice
    • NHS boards
    • Patient and Public Involvement
    • Industry Involvement
    • Observe a council meeting
    • DOI Form

SHTG Recommendation

  • Home
  • Our Advice
  • Bacteriophage therapy

Technology Assessment

Speciality

Output Type

Expected

Technology Assessment

Bacteriophage therapy

Speciality

Endocrine, nutritional and metabolic, Respiratory system, Infectious disease, Genitourinary system, Injuries, accidents and wounds, Paediatrics, Dermatology

Output Type

SHTG Recommendation

Expected

10 February 2023

What were we asked to look at?  

The Scottish Health Technologies Group (SHTG) was asked to evaluate the clinical effectiveness, cost effectiveness, safety and patient experience of bacteriophage therapy in patients whose clinical needs are not met by antibiotics (e.g. where bacteria have developed resistance to multiple antibiotics). 

Why is this important 

The prevalence of antibiotic resistance is increasing worldwide, with new resistance mechanisms emerging and spreading globally. As a results of this, bacterial infections are becoming harder, and in some situations impossible, to treat effectively leading to longer hospital stays, higher medical costs and increased mortality.  

NHS Tayside have received initial funding to create a Bacteriophage Unit within their health board starting in February 2022. A report outlining the operations of the service and business case are required to be submitted to NHS National Services Scotland 6 months after the service has begun. SHTG's work will be used alongside data collected by the service to inform a decision regarding continued funding. 

Referred by  

A Research Virologist and a Clinical Director & Consultant Vascular Surgeon at NHS Tayside. 

Project Status  

In progress 

Publication Status

Draft in development
Download icon
Download Project Scope
pdf (541 KB)
Form icon

Register Interest


Connect with Us

Please let us know if you'd like to receive regular updates on our work.


Last Updated: 1 February 2023

Scottish Health Technologies Group

© 2021, All rights reserved

  • Accessibility
  • Respecting your privacy
  • Cookies
  • Healthcare Improvement Scotland Website
  • Find us on Twitter
  • Freedom of Information

Tell us what you think


We'd love to hear your views

Was our advice useful?  Did you find what you were looking for on our website?